Mybiotics Pharma Ltd
Mybiotics Pharma Ltd., headquartered in Israel, is a pioneering company in the biotechnology sector, specialising in the development of innovative microbiome-based therapeutics. Founded in 2015, Mybiotics has rapidly established itself as a leader in the field, focusing on the gut microbiome's role in health and disease. The company’s core offerings include advanced probiotic formulations and personalised microbiome solutions, designed to enhance gut health and overall well-being. Mybiotics Pharma distinguishes itself through its commitment to scientific research and development, ensuring that its products are backed by robust clinical evidence. With a strong presence in both local and international markets, Mybiotics has achieved significant milestones, including collaborations with leading research institutions. This positions the company as a notable player in the biotechnology landscape, dedicated to transforming health through microbiome science.
DitchCarbon Score
How does Mybiotics Pharma Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Mybiotics Pharma Ltd's score of 18 is lower than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Mybiotics Pharma Ltd's reported carbon emissions
Mybiotics Pharma Ltd, headquartered in Israel (IL), currently does not have available carbon emissions data for recent years. As a result, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not provided. Despite the absence of emissions data, Mybiotics Pharma Ltd is committed to addressing climate change through various initiatives. However, no specific reduction targets or climate pledges have been disclosed. The company operates within an industry increasingly focused on sustainability and reducing environmental impact, indicating a potential alignment with broader climate commitments. As the landscape of corporate climate responsibility evolves, it will be essential for Mybiotics Pharma Ltd to establish measurable targets and transparent reporting to enhance their sustainability profile.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Mybiotics Pharma Ltd is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
